A long-chain fatty acid KD was chosen due to its proposed ability to prevent hypoxia-inducible factor-1α (HIF-1α) signaling, a pathway whose activation has been linked to MS with recent studies revealing mitigation of MS symptoms upon its inhibition (28, 29). This evidence concerns the gene HIF1A and myeloid sarcoma.